Manufacturing peptides—whether as bulk API, research chemicals, or finished formulations—creates significant product liability exposure. This guide explains what peptide manufacturers need to know about protecting their business.
PRIA Brokers
PRIA Brokers — Peptide Insurance Specialist
Peptide manufacturing sits at the intersection of pharmaceuticals, biotechnology, and specialty chemicals. That intersection creates a product liability exposure that standard commercial insurance programs are not designed to address.
Whether you manufacture:
Bulk peptide API (active pharmaceutical ingredients)
Research-use peptides
Finished compounded products
Peptide-based nutraceuticals or cosmetics
...you face the potential for claims that trace back to your product long after it leaves your facility.
In the peptide supply chain, liability doesn't stop at the manufacturer's loading dock. If a downstream user—a compounder, a clinic, a patient—suffers harm that's traceable to your product, you can expect to be named in any resulting lawsuit.
Courts in the United States routinely apply strict liability to product manufacturers. This means a claimant doesn't have to prove negligence—only that the product was defective and caused harm. Defects can be:
**Manufacturing defects** – contamination, improper synthesis, incorrect purity
**Design defects** – inherent risks in the peptide's formulation
**Warning defects** – inadequate labeling or failure to disclose known risks
Most commercial general liability policies exclude:
Professional or technical services
Products intended for human consumption or injection
Pharmaceutical or drug-related products
Errors in formulation or testing
This leaves peptide manufacturers with a significant gap. A claim that your peptide caused harm to a patient could easily reach seven or eight figures—and your standard GL policy may decline coverage entirely.
PRIA Brokers structures product liability programs specifically for the peptide industry. Coverage typically includes:
**Bodily Injury and Property Damage**
Covers claims by third parties—patients, distributors, end-users—who allege harm caused by your product.
**Defense Costs**
In pharmaceutical litigation, legal defense can exceed the underlying settlement. Adequate limits must account for both.
**Product Recall**
If a batch is found to be contaminated or mislabeled, recall coverage pays for the retrieval and destruction of product, as well as notification costs and business interruption losses.
**Errors & Omissions**
For manufacturers that provide technical specifications, COAs (certificates of analysis), or consulting services, E&O coverage protects against claims that your professional guidance caused a downstream loss.
Manufacturers who operate under FDA oversight—whether as a registered facility or under a CGMP-compliant framework—often find that insurers are more willing to offer competitive terms. Insurers evaluate:
GMP compliance and third-party audits
Quality management systems (QMS)
CoA documentation and third-party testing protocols
Recall procedures and crisis management plans
Investing in compliance infrastructure doesn't just reduce the likelihood of a claim—it directly impacts your insurability and premium.
There's no universal answer, but the following factors drive limit selection for peptide manufacturers:
**Annual revenue** – a common benchmark is 10-20% of revenue for combined limits
**Distribution geography** – U.S. distribution triggers higher risk than purely international sales
**End use** – human-use peptides require higher limits than research chemicals
**Customer profile** – supplying compounding pharmacies creates different exposure than supplying research universities
**Contract requirements** – many downstream customers will specify minimum limits in their supply agreements
PRIA Brokers works with manufacturers to model these factors and design programs that are neither under-insured nor wastefully over-insured.
PRIA Brokers has placed coverage for peptide manufacturers ranging from small domestic API producers to large-scale international suppliers. Our underwriting relationships with specialty markets mean we can access capacity that general commercial brokers cannot.
Contact us at (888) 998-7742 or info@priabrokers.com to discuss your manufacturing operation and get a coverage proposal.
PRIA Brokers specializes in coverage for peptide manufacturers, GLP-1 compounders, distributors, and suppliers. Compare quotes from A-rated specialty carriers.